Kyp-Vell Medics Limited 14495802 false 2022-11-21 2023-11-30 2023-11-30 The principal activity of the company is General medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 14495802 2022-11-21 2023-11-30 14495802 2023-11-30 14495802 bus:Director3 1 2023-11-30 14495802 core:CurrentFinancialInstruments core:WithinOneYear 2023-11-30 14495802 bus:Micro-entities 2022-11-21 2023-11-30 14495802 bus:AuditExemptWithAccountantsReport 2022-11-21 2023-11-30 14495802 bus:FullAccounts 2022-11-21 2023-11-30 14495802 bus:SmallCompaniesRegimeForAccounts 2022-11-21 2023-11-30 14495802 bus:RegisteredOffice 2022-11-21 2023-11-30 14495802 bus:Director1 2022-11-21 2023-11-30 14495802 bus:Director2 2022-11-21 2023-11-30 14495802 bus:Director3 2022-11-21 2023-11-30 14495802 bus:Director3 1 2022-11-21 2023-11-30 14495802 bus:PrivateLimitedCompanyLtd 2022-11-21 2023-11-30 14495802 countries:EnglandWales 2022-11-21 2023-11-30 14495802 bus:Director3 1 2022-11-20 iso4217:GBP xbrli:pure

Registration number: 14495802

Kyp-Vell Medics Limited

Unaudited Filleted Financial Statements

for the Period from 21 November 2022 to 30 November 2023

 

Kyp-Vell Medics Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Kyp-Vell Medics Limited

Company Information

Directors

Dr P Kypa

M Vellala

Dr R P Vellala

Registered office

Ramsay Brown Llp The Brentano Suite, Solar House, 915 High Road
London
N12 8QJ

 

Kyp-Vell Medics Limited

(Registration number: 14495802)
Balance Sheet as at 30 November 2023

2023
£

Fixed assets

7,568

Current assets

37,293

Creditors: Amounts falling due within one year

(8,250)

Net current assets

29,043

 

36,611

Capital and reserves

36,611

1

General information

The company is a private company limited by share capital incorporated in England and Wales and the company registration number is 14495802.

The address of its registered office is:
Ramsay Brown Llp The Brentano Suite, Solar House, 915 High Road
London
N12 8QJ
United Kingdom

These financial statements were authorised for issue by the Board on 14 August 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The financial statements have been prepared in sterling and are rounded to the nearest pound.

The financial statements cover the individual entity, Kyp-Vell Medics Limited.

2

Staff numbers

The average number of persons employed by the Company (including Directors) during the period, was 3.

3

Related party transactions

The below advances were unsecured and had no fixed repayment date, no interest has been charged on balance.

2023

At 21 November 2022
£

Advances to Director
£

Repayments by Director
£

At 30 November 2023
£

Dr R P Vellala

-

5,510

(3,245)

2,265

         
       

 

For the financial period ending 30 November 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

 

Kyp-Vell Medics Limited

(Registration number: 14495802)
Balance Sheet as at 30 November 2023

Directors' responsibilities:

The members have not required the Company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the Directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 14 August 2024 and signed on its behalf by:
 

.........................................
Dr R P Vellala
Director